Find a Commonwealth Resource
Entrectinib
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Rozlytrek (entrectinib) is an oral prescription drug by Genentech, Inc., used to treat certain cancers like lung cancer with ROS1 gene changes or solid tumors with NTRK fusions. It comes as 50 mg pellets in dose packs. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Entrectinib
Access the FDA dataset for Entrectinib — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025